Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Semaglutide is a GLP-1 receptor agonist that mimics a hormone produced in the gut after eating
Until stereoisomer-specific studies and formal pharmacovigilance data are available, any long-term or high-dose use carries unknown risk
A provider will assess your goals, labs, and health history to tailor a plan that prioritizes both safety and results
A growing body of clinical evidence supporting tirzepatide is one reason insurers are evaluating coverage for Zepbound
The Research Behind It A landmark 2021 trial published in the New England Journal of Medicine (Wilding et al.) found that once-weekly semaglutide 2.4 mg produced an average body weight reduction of 14.9% over 68 weeks in adults with obesity, compared to 2.4% in the placebo group
This is the part patients are most often surprised by
US$ 20.19
US$ 25.08
US$ 20.83
US$ 25.05
US$ 20.47
US$ 21.70
US$ 28.13
